Online ISSN: 3007-0244,
Print ISSN:  2410-4280
CONGENITAL HEART DISEASES AND CONNECTIVE TISSUE DYSPLASIA CHILDREN OF SEMEY, THE DETERMINATION THE FREQUENCY
Introduction. The community of pathogenetic mechanisms of congenital heart diseases and connective tissue dysplasia connective tissue dysplasia defines increase in risk of their combinations. At the same time perhaps essential deterioration in the forecast of a current and conditions for correction of connective tissue dysplasia. So far poorly studied are an actual frequency and structure of combinations of these pathological states in population. Research objective – to determine the frequency of signs connective tissue dysplasia in children with connective tissue dysplasia are living in Semey sity. Materials and methods. the study was conducted on the basis of the medical center of the state medical University of Semey pediatric Department. The study was conducted in the period 2016-2018. This work is a retro-prospective, analytical experimental clinical and epidemiological study. 168 children aged 1 to 14 years were examined, including 84 children with connective tissue dysplasia and 84 healthy children of the control group. Definition of physical signs of connective tissue dysplasia at the first stage of diagnostics and assessment of visceral signs of systemic involvement at the second stage is carried out. The comparative analysis was carried out also taking into account connective tissue dysplasia option. For a statistical analysis of tables of an associativity used unilateral precise criterion of Fischer and criterion χ2. Results of a research: Children with VPS and with connective tissue dysplasia had quite comparable frequency of phenotypical signs of the last. Significant excess of the frequenciest indexes over control group on the majority of signs was observed. Instrumental researches of heart showed very high frequency of signs of connective tissue dysplasia at children about connective tissue dysplasia. It is revealed that undifferentiated connective tissue dysplasia is almost inevitable accompanying syndrome at children with connective tissue dysplasia, being observed in 88,1% of cases. The frequency of external and visceral signs of connective tissue dysplasia in children with congenital malformations was higher than in children with connective tissue dysplasia of 2-3 degrees. Severe dysplasia of connective tissue is characteristic of pulmonary artery stenosis, tetralogy of Fallot, transposition of CAPD, great vessels, coarctation of the aorta in the presence of bicuspidal aortic valve. Relative risk of birth in women with connective tissue dysplasia 2-3 degrees in children with congenital heart defects RR=12.5 ,2=98.23 (p<0.001)
Aizhan Z. Abylgazinova 1, Aliya R. Alimbaeva 1, Gulnara B. Tiorazova 1 1 Department of Pediatrics, Semey State Medical University. Semey, the Republic of Kazakhstan
1. Бубнова Н.И., Жакота Д.A., Каск Л.Н. и соавт. Кардиопатии у детей // Арх.патологии. 2010. Т.72,6. С.11-16. 2. Кадурина Т.И., Горбунова В.Н. Дисплазия соединительной ткани. СПб.: Элби, 2009. 714 с. 3. Нестеренко З.В. Классификационные концепции дисплазии соединительной ткани // Здоровье ребенка. 2010. № 5 (26). С.131-135. 4. Нечаева Г.И., Яковлев В.М., Конев В.П. и соавт. Дисплазия соединительной ткани: основные клинические синдромы, формулировка диагноза, лечение // Лечащий врач. 2008. № 2. С. 22–28. 5. Чемоданов В.В., Краснова Е.Е. Особенности течения заболеваний у детей с дисплазией соединительной ткани. Иваново, 2010. 140 с. 6. Asimaki A., Protonotarios A., James C.A. et al. Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells // Circ Arrhythm Electrophysiol. 2016. Vol.9(2). С.36-88. 7. Azhar M., Ware S.M. Genetic and Developmental Basis of Cardiovascular Malformations // Clin Perinatol. 2016. Vol.43(1). P.39-53. 8. Barker D.J., Eriksson J.G., Forsén T., Osmond C. Fetal origins of adult disease: strength of effects and biological basis // Int J Epidemiol. 2002. Vol.31(6). – P.1235-1239. 9. Budde B.S., Mizumoto S., Kogawa R. et al. Skeletal dysplasia in a consanguineous clan from the island of Nias/Indonesia is caused by a novel mutation in B3GAT3 // Hum Genet. 2015. Vol.134(7). P.691-704. 10. Chaabane S., Bérard A. Epidemiology of major congenital malformations with specific focus on teratogens // Curr Drug Saf. 2013.Vol.8(2). – P.128-140. 11. Cui Y., Zhao H., Liu Z. et al. A systematic review of genetic skeletal disorders reported in Chinese biomedical journals between 1978 and 2012 // Orphanet J Rare Dis. 2012. Vol.22;7. P.55. 12. Elkayam U., Goland S., Pieper P.G., Silverside C.K. High-Risk Cardiac Disease in Pregnancy: Part II // J Am Coll Cardiol. 2016. - Jul 1. pii: S0735-1097(16)33354-X. 13. Jensen S.A., Handford P.A. New insights into the structure, assembly and biological roles of 10-12 nm connective tissue microfibrils from fibrillin-1 studies // Biochem J. 2016. Vol.473(7). P.827-838. 14. Nandi D., Rossano J.W. Epidemiology and cost of heart failure in children // Cardiol Young. 2015. Vol.25(8). P.1460-1468. 15. Osovska N., Kuzminova N., Ovcharuk M., Serhiychuk O. Structural heart anomalies // Georgian Med News. 2016. Vol.255. P.66-77. 16. Pasquali S.K., Jacobs J.P., Farber G.K. et al. Report of the National Heart, Lung, and Blood Institute Working Group: An Integrated Network for Congenital Heart Disease Research // Circulation. 2016. Vol.133(14). P.1410-1418. 17. Pereira Albino J. Congenital vascular malformations: epidemiology, classification and therapeutic basis // Rev Port Cir Cardiotorac Vasc. 2010. Vol.17(1). P.61-66. 18. Potter C.A., Armstrong-Wells J., Fullerton H.J. et al. Neonatal giant pial arteriovenous malformation: genesis or rapid enlargement in the third trimester // J Neurointerv Surg. 2009. Vol.1(2). P.151-153. 19. Sato H., Shiraishi I., Takamatsu T., Hamaoka K. Detection of TUNEL-positive cardiomyocytes and c-kit-positive progenitor cells in children with congenital heart disease // J Mol Cell Cardiol. 2007. Vol.43(3). P.254-261. 20. Seckeler M.D., Thomas I.D., Andrews J., Joiner K., Klewer S.E. A review of the economics of adult congenital heart disease // Expert Rev Pharmacoecon Outcomes Res. 2016. Vol.16(1). P.85-96. 21. Shivapour D.M., Erwin P., Kim E.Sh. Epidemiology of fibromuscular dysplasia: A review of the literature // Vasc Med. 2016. Vol.21(4). P.376-381. 22. Weiss K., Applegate C., Wang T., Batista D.A. Familial TAB2 microdeletion and congenital heart defects including unusual valve dysplasia and tetralogy of Fallot // Am J Med Genet A. 2015.Vol.167A(11). P.2702-2706. 23. Zhu X., Wang Y., Zhao G. et al. Phenotypic and genetic analysis of a child with blepharophimosis, ptosis, epicanthus inverses syndrome and tetralogy of Fallot // Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015. Vol.32(5). P.670-673. References: 1. Bubnova N.I., Zhakota D.A., Kask L.N. et al. Kardiopatii u detei [Cardiopathies in children]. Arkhiv patologii [Archive of pathology]. 2010, 6, рр.11-16. [in Russian] 2. Kadurina T.I., Gorbunova V.N. Displaziya soedinitel'noi tkani [Connective tissue dysplasia]. Sant-Peterburg: Elby, 2009. 714 p. [in Russian] 3. Nesterenko Z.V. Klassifikatsionnye kontseptsii displazii soedinitel'noi tkani [Classification conceptions of connective tissue dysplasia]. Zdorov'e rebenka [Child health]. 2010. 5(26). P.131-135. [in Russian] 4. Nechaeva G.I., Yakovlev V.M., Konev V.P. et al. Displaziya soedinitel'noi tkani: osnovnye klinicheskie sindromy, formulirovka diagnoza, lechenie [Connective tissue dysplasia: basic clinical syndromes, diagnosis and treatment]. Lech.vrach [Doctor]. 2008, 2. P.22-28. [in Russian] 5. Chemodanov V.V., Krasnova E.E. Osobennosti techeniya zabolevanii u detei s displaziei soedinitel'noi tkani [Featurs of diseases course in children with connective tissue dysplasia]. – Ivanovo, 2010. 140 p. [in Russian] 6. Asimaki A., Protonotarios A., James C.A. et al. Characterizing the Molecular Pathology of Arrhythmogenic Cardiomyopathy in Patient Buccal Mucosa Cells. Circ Arrhythm Electrophysiol. 2016, 2. Р.36-88. 7. Azhar M., Ware S.M. Genetic and Developmental Basis of Cardiovascular Malformations. Clin Perinatol. 2016. Vol.43(1). P.39-53. 8. Barker D.J., Eriksson J.G., Forsén T., Osmond C. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol. 2002. Vol.31(6). P.1235-1239. 9. Budde B.S., Mizumoto S., Kogawa R. et al. Skeletal dysplasia in a consanguineous clan from the island of Nias / Indonesia is caused by a novel mutation in B3GAT3. Hum Genet. 2015. Vol.134(7). P.691-704. 10. Chaabane S., Bérard A. Epidemiology of major congenital malformations with specific focus on teratogens. Curr Drug Saf. 2013. Vol.8(2). P.128-140. 11. Cui Y., Zhao H., Liu Z. et al. A systematic review of genetic skeletal disorders reported in Chinese biomedical journals between 1978 and 2012. Orphanet J Rare Dis. 2012. Vol.22;7. P.55. 12. Elkayam U., Goland S., Pieper P.G., Silverside C.K. High-Risk Cardiac Disease in Pregnancy: Part II. J Am Coll Cardiol. 2016. Jul 1. pii: S0735-1097(16)33354-X. 13. Jensen S.A., Handford P.A. New insights into the structure, assembly and biological roles of 10-12 nm connective tissue microfibrils from fibrillin-1 studies. Biochem J. 2016. Vol.473(7). P.827-838. 14. Nandi D., Rossano J.W. Epidemiology and cost of heart failure in children. Cardiol Young. 2015. Vol.25(8). P.1460-1468. 15. Osovska N., Kuzminova N., Ovcharuk M., Serhiychuk O. Structural heart anomalies. Georgian Med News. 2016. Vol.255. P.66-77. 16. Pasquali S.K., Jacobs J.P., Farber G.K. et al. Report of the National Heart, Lung, and Blood Institute Working Group: An Integrated Network for Congenital Heart Disease Research. Circulation. 2016. Vol.133(14). P.1410-1418. 17. Pereira Albino J. Congenital vascular malformations: epidemiology, classification and therapeutic basis. Rev Port Cir Cardiotorac Vasc. 2010. Vol.17(1). P.61-66. 18. Potter C.A., Armstrong-Wells J., Fullerton H.J. et al. Neonatal giant pial arteriovenous malformation: genesis or rapid enlargement in the third trimester. J Neurointerv Surg. 2009. Vol.1(2). P.151-153. 19. Sato H., Shiraishi I., Takamatsu T., Hamaoka K. Detection of TUNEL-positive cardiomyocytes and c-kit-positive progenitor cells in children with congenital heart disease. J Mol Cell Cardiol. 2007. Vol.43(3). P.254-261. 20. Seckeler M.D., Thomas I.D., Andrews J., Joiner K., Klewer S.E. A review of the economics of adult congenital heart disease. Expert Rev Pharmacoecon Outcomes Res. 2016. Vol.16(1). P.85-96. 21. Shivapour D.M., Erwin P., Kim E.Sh. Epidemiology of fibromuscular dysplasia: A review of the literature. Vasc Med. 2016. Vol.21(4). P.376-381. 22. Weiss K., Applegate C., Wang T., Batista D.A. Familial TAB2 microdeletion and congenital heart defects including unusual valve dysplasia and tetralogy of Fallot. Am J Med Genet A. 2015. Vol.167A(11). P.2702-2706. 23. Zhu X., Wang Y., Zhao G. et al. Phenotypic and genetic analysis of a child with blepharophimosis, ptosis, epicanthus inverses syndrome and tetralogy of Fallot. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2015. Vol.32(5). P.670-673.
Number of Views: 317

Key words:

Category of articles: Original article

Bibliography link

Абылгазинова А.Ж., Алимбаева А.Р., Тайоразова Г.Б. Частота признаков дисплазии соединительной ткани и врожденных пороков сердца у детей города Семей // Наука и Здравоохранение. 2018. 5 (Т.20). С. 145-152. Abylgazinova A.Z., Alimbaeva A.R., Tiorazova G.B. Congenital heart diseases and connective tissue dysplasia children of Semey, the determination the frequency. Nauka i Zdravookhranenie [Science & Healthcare]. 2018, (Vol.20) 5, pp. 145-152. Абылгазинова А.Ж., Алимбаева А.Р., Тайоразова Г.Б. Семей қаласының балаларындағы туа біткен жүрек ақауы мен дәнекер тін дисплазиясының жилігін анықтау // Ғылым және Денсаулық сақтау. 2018. 5 (Т.20). Б. 145-152.

Авторизируйтесь для отправки комментариев